European Commission Grants Conditional Marketing Authorization for Gilead’s Veklury for the Treatment of COVID-19
Gilead Sciences today announced that the European Commission has granted conditional marketing authorization for Veklury (remdesivir) as a treatment for...
Merck Animal Health Acquires US Rights to SENTINEL Brand of Combination Parasiticides for Companion Animals
Merck Animal Health today announced the completion of its previously announced acquisition of the US rights to Sentinel Flavor Tabs...
Merck and Ridgeback Bio Announce Closing of Collaboration and Licensing Transaction
Merck and Ridgeback Biotherapeutics today announced that the US Federal Trade Commission granted early termination of the waiting period under...
Pfizer and BioNTech Announce Early Positive Data from Phase 1/2 Study of mRNA-based Vaccine Candidate for SARS-CoV-2
Pfizer and BioNTech today announced preliminary US data from the most advanced of four investigational vaccine candidates from their BNT162...
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
Sol-Gel Technologies announced that it has entered into collaborative agreements with Perrigo Company for the development, manufacturing and commercialization of...
Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
Abbott Tandem Diabetes Care have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading continuous...
An Open Letter from Daniel O’Day, Chairman and CEO, Gilead Sciences
In the weeks since we learned of remdesivir’s potential against COVID-19, one topic has attracted more speculation than any other:...